Carroll Financial Associates’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $118K | Sell |
2,757
-1,365
| -33% | -$58.4K | 0.01% | 494 |
|
|
2021
Q3 | $178K | Buy |
4,122
+27
| +0.7% | +$1.17K | 0.01% | 420 |
|
|
2021
Q2 | $175K | Buy |
4,095
+8
| +0.2% | +$342 | 0.01% | 442 |
|
|
2021
Q1 | $157K | Buy |
4,087
+17
| +0.4% | +$653 | 0.01% | 448 |
|
|
2020
Q4 | $146K | Hold |
4,070
| – | – | 0.01% | 437 |
|
|
2020
Q3 | $155K | Hold |
4,070
| – | – | 0.01% | 381 |
|
|
2020
Q2 | $142K | Hold |
4,070
| – | – | 0.01% | 390 |
|
|
2020
Q1 | $132K | Sell |
4,070
-130
| -3% | -$4.22K | 0.01% | 368 |
|
|
2019
Q4 | $189K | Hold |
4,200
| – | – | 0.02% | 373 |
|
|
2019
Q3 | $170K | Hold |
4,200
| – | – | 0.01% | 396 |
|
|
2019
Q2 | $180K | Buy |
4,200
+1,469
| +54% | +$63K | 0.02% | 368 |
|
|
2019
Q1 | $104K | Sell |
2,731
-17
| -0.6% | -$647 | 0.01% | 439 |
|
|
2018
Q4 | $94K | Sell |
2,748
-17
| -0.6% | -$582 | 0.01% | 380 |
|
|
2018
Q3 | $106K | Sell |
2,765
-269
| -9% | -$10.3K | 0.01% | 373 |
|
|
2018
Q2 | $99K | Hold |
3,034
| – | – | 0.01% | 380 |
|
|
2018
Q1 | $82K | Buy |
3,034
+307
| +11% | +$8.3K | 0.01% | 411 |
|
|
2017
Q4 | $67K | Hold |
2,727
| – | – | 0.01% | 436 |
|
|
2017
Q3 | $80K | Buy |
2,727
+227
| +9% | +$6.66K | 0.01% | 408 |
|
|
2017
Q2 | $69K | Hold |
2,500
| – | – | 0.01% | 431 |
|
|
2017
Q1 | $62K | Hold |
2,500
| – | – | 0.01% | 432 |
|
|
2016
Q4 | $54K | Hold |
2,500
| – | – | 0.01% | 447 |
|
|
2016
Q3 | $59K | Hold |
2,500
| – | – | 0.01% | 434 |
|
|
2016
Q2 | $58K | Hold |
2,500
| – | – | 0.01% | 422 |
|
|
2016
Q1 | $47K | Buy |
+2,500
| New | +$47K | 0.01% | 440 |
|
|
2013
Q4 | – | Sell |
-200
| Closed | -$2K | – | 809 |
|
|
2013
Q3 | $2K | Hold |
200
| – | – | ﹤0.01% | 684 |
|
|
2013
Q2 | $1K | Buy |
+200
| New | +$1K | ﹤0.01% | 571 |
|